Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival

Abstract Background NETTER-1 trial demonstrated high efficacy and low toxicity of four cycles of Peptide Receptor Radionuclide Therapy (PRRT) in patients with metastasized NET. The present study evaluates the outcome of further PRRT cycles in the so called salvage setting in patients after initial r...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: S. Rudisile, A. Gosewisch, V. Wenter, M. Unterrainer, G. Böning, F. J. Gildehaus, W. P. Fendler, C. J. Auernhammer, C. Spitzweg, P. Bartenstein, A. Todica, H. Ilhan
Formáid: Artigo
Teanga:Inglês
Foilsithe: BMC 2019-08-01
Sraith:BMC Cancer
Ábhair:
PRRT
Salvage therapy
NET
SPECT
Dosimetry
Survival
Rochtain Ar Líne:http://link.springer.com/article/10.1186/s12885-019-6000-y
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla